Movement Disorders and Inherited Metabolic Disorders. Recognition, Understanding, Improving Outcomes (Print + Online)

Section I. General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders:
1. Treatable Metabolic Movement Disorders: the Top 10
2. The Importance of Movement Disorders in Inborn Errors of Metabolism
3. The Importance of Inborn Errors of Metabolism for Movement Disorders
4. Imaging in Metabolic Movement Disorders
5. Biochemical Testing for Metabolic Movement Disorders
6. Genetic Testing for Metabolic Movement Disorders
7. A Phenomenology-Based approach to inborn errors of metabolism with Ataxia
8. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Dystonia
9. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Parkinsonism
10. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Spasticity
11. A Phenomenology-Based Approach to Inborn Errors of Metabolism with Myoclonus
Section II. A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders:
12. Disorders of Amino Acid Metabolism: Amino Acid Disorders, Organic Acidurias, and Urea Cycle Disorders with Movement Disorders
13. Disorders of Energy Metabolism: Glut1 Deficiency Syndrome and Movement Disorders
14. Lysosomal Storage Disorders: Niemann-Pick Disease Type C and Movement Disorders
15. Lysosomal Storage Disorders: Neuronal Ceroid Lipofuscinoses and Movement Disorders
16. Syndromes of Neurodegeneration with Brain Iron Accumulation
17. Metal Storage Disorders: Inherited Disorders of Copper and Manganese Metabolism and Movement Disorders
18. Metal Storage Disorders: Primary Familial brain Calcification and Movement Disorders
19. Disorders of Glycosylation and Movement Disorders
20. Disorders of Post-translational Modifications / Degradation: Disorders of Autophagy and Movement Disorders
21. Neurotransmitter Disorders: Disorders of Dopamine Metabolism and Movement Disorders
22. Disorders of GABA Metabolism and Movement Disorders
23. DNAJC12-deficient Hyperphenylalaninemia – An Emerging Neurotransmitter Disorder
24. Vitamin-Responsive Disorders: Ataxia with Vitamin E Deficiency and Movement Disorders
25. Vitamin-Responsive Disorders: Biotin-Thiamin Responsive Basal Ganglia Disease and Movement Disorders
26. Disorders of Cholesterol Metabolism: Cerebrotendinous Xanthomatosis and Movement Disorders
27. Purine Metabolism Defects: the Movement Disorder of Lesch-Nyhan Disease
28. Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders
29. Hereditary Spastic Paraplegia Related Inborn Errors of Metabolism
Section III. Conclusions and Future Directions:
30. Metabolic Movement Disorders in the Era of Next-Generation Sequencing
31. Deep Brain Stimulation for Metabolic Movement Disorders
32. Novel Therapeutic Approaches to Metabolic Movement Disorders
Closing Remarks: A Clinical approach to Inherited Metabolic Movement Disorders.

Inherited metabolic movement disorders are a significant and rapidly evolving field of study, linking two subspecialty areas of childhood-onset movement disorders and inborn errors of metabolism. Increasing the chance of early recognition of inherited metabolic movement disorders can have significant therapeutic implications for patients. Containing information on new disorders of post-translational modification and autophagy and their identification and treatment, there is thorough coverage of disorders of amino acids, energy metabolism, and lysosomal storage, amongst others. This key resource explores future directions in the field including next-generation genetic sequencing and novel therapeutic approaches such as deep brain stimulation. Supplementary videos are available on Cambridge Core, accessible via the code printed inside the cover. This essential text bridges the gap in communication between experts in genetic-metabolic medicine and movement disorder neurology. With an emphasis on treatable conditions that should not be missed, this volume guides you through various disorders from a clinical, biochemical and genetic perspective.

• Brings together experts in genetic-metabolic medicine and movement disorder neurology, providing a complete understanding of the clinical, biochemical and genetic basis of the disorders
• Gain full HTML access of the whole book, with expandable videos, figures and resources, via a scratch-off code inside the cover
• In a rapidly expanding field, the book explores newly discovered disorders as well as more recognised diseases
• Covers future directions in the field such as new technology to diagnose disorders and novel therapeutic approaches
• Highly experienced contributors from around the world bring a wealth of understanding and knowledge together in one source
• A readable and well-illustrated reference for clinicians and scientists

Darius Ebrahimi-Fakhari, Harvard Medical School
Darius Ebrahimi-Fakhari is a Physician-Scientist at the Department of Neurology at Boston Children's Hospital. He is the recipient of the Outstanding Junior Member Award from the Child Neurology Society and the Young Investigator Award from the German Society for Pediatric Neurology.

Phillip L. Pearl, Harvard Medical School
Phillip L. Pearl is the William G. Lennox Chair and Professor of Neurology at Harvard Medical School and Director of Epilepsy and Clinical Neurophysiology at Boston Children's Hospital. He is the Past President of the Professors of Child Neurology and President-Elect of the Child Neurology Society. He is the editor of Inherited Metabolic Epilepsies (2018) and several other textbooks.